These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 26634453

  • 1. Botulinum neurotoxin type A in the treatment of classical Trigeminal Neuralgia (BoTN): study protocol for a randomized controlled trial.
    Burmeister J, Holle D, Bock E, Ose C, Diener HC, Obermann M.
    Trials; 2015 Dec 03; 16():550. PubMed ID: 26634453
    [Abstract] [Full Text] [Related]

  • 2. Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial.
    Zhang H, Lian Y, Ma Y, Chen Y, He C, Xie N, Wu C.
    J Headache Pain; 2014 Sep 27; 15(1):65. PubMed ID: 25263254
    [Abstract] [Full Text] [Related]

  • 3. The WE-Study: does botulinum toxin A make walking easier in children with cerebral palsy?: Study protocol for a randomized controlled trial.
    Brændvik SM, Roeleveld K, Andersen GL, Raftemo AE, Ramstad K, Majkic-Tajsic J, Lamvik T, Lund B, Follestad T, Vik T.
    Trials; 2017 Feb 06; 18(1):58. PubMed ID: 28166806
    [Abstract] [Full Text] [Related]

  • 4. Beneficial effects of botulinum toxin type A in trigeminal neuralgia.
    Zúñiga C, Díaz S, Piedimonte F, Micheli F.
    Arq Neuropsiquiatr; 2008 Sep 06; 66(3A):500-3. PubMed ID: 18813708
    [Abstract] [Full Text] [Related]

  • 5. Botulinum toxin and intractable trigeminal neuralgia.
    Türk U, Ilhan S, Alp R, Sur H.
    Clin Neuropharmacol; 2005 Sep 06; 28(4):161-2. PubMed ID: 16062093
    [Abstract] [Full Text] [Related]

  • 6. Injections of botulinum toxin type a produce pain alleviation in intractable trigeminal neuralgia.
    Allam N, Brasil-Neto JP, Brown G, Tomaz C.
    Clin J Pain; 2005 Sep 06; 21(2):182-4. PubMed ID: 15722812
    [Abstract] [Full Text] [Related]

  • 7. Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial.
    Attal N, de Andrade DC, Adam F, Ranoux D, Teixeira MJ, Galhardoni R, Raicher I, Üçeyler N, Sommer C, Bouhassira D.
    Lancet Neurol; 2016 May 06; 15(6):555-65. PubMed ID: 26947719
    [Abstract] [Full Text] [Related]

  • 8. Single-dose botulinum toxin type a compared with repeated-dose for treatment of trigeminal neuralgia: a pilot study.
    Zhang H, Lian Y, Xie N, Chen C, Zheng Y.
    J Headache Pain; 2017 Aug 10; 18(1):81. PubMed ID: 28799056
    [Abstract] [Full Text] [Related]

  • 9. Acute treatment of trigeminal neuralgia with onabotulinum toxin A.
    Zúñiga C, Piedimonte F, Díaz S, Micheli F.
    Clin Neuropharmacol; 2013 Aug 10; 36(5):146-50. PubMed ID: 24045604
    [Abstract] [Full Text] [Related]

  • 10. Increasing relief with repeated botulinum neurotoxin A injections in a rare case of hemi facial spasm with contralateral trigeminal autonomic orofacial pain and occipital neuralgia: A case report.
    Punj J, Singh P.
    Toxicon; 2023 Jun 01; 228():107120. PubMed ID: 37031873
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: a systematic review.
    Hu Y, Guan X, Fan L, Li M, Liao Y, Nie Z, Jin L.
    J Headache Pain; 2013 Aug 21; 14(1):72. PubMed ID: 23964790
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and Safety of Single Botulinum Toxin Type A (Botox®) Injection for Relief of Upper Trapezius Myofascial Trigger Point: A Randomized, Double-Blind, Placebo-Controlled Study.
    Kwanchuay P, Petchnumsin T, Yiemsiri P, Pasuk N, Srikanok W, Hathaiareerug C.
    J Med Assoc Thai; 2015 Dec 21; 98(12):1231-6. PubMed ID: 27004309
    [Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of erenumab in patients with trigeminal neuralgia in Denmark: a double-blind, randomised, placebo-controlled, proof-of-concept study.
    Schott Andersen AS, Maarbjerg S, Noory N, Heinskou TB, Forman JL, Cruccu G, Ashina M, Bendtsen L.
    Lancet Neurol; 2022 Nov 21; 21(11):994-1003. PubMed ID: 36113495
    [Abstract] [Full Text] [Related]

  • 14. Trigeminal Neuralgia With Extraoral Trigger Zone Successfully Treated With Intraoral Injections of Botulinum Toxin: A Case Report.
    Dinan JE, Smith A, Hawkins JM.
    Clin Neuropharmacol; 2020 Nov 21; 43(5):162-163. PubMed ID: 32947428
    [Abstract] [Full Text] [Related]

  • 15. Neuromodulators for Atypical Facial Pain and Neuralgias: A Systematic Review and Meta-Analysis.
    Do TM, Unis GD, Kattar N, Ananth A, McCoul ED.
    Laryngoscope; 2021 Jun 21; 131(6):1235-1253. PubMed ID: 33037835
    [Abstract] [Full Text] [Related]

  • 16. Is Botulinum Toxin Type A a Valuable Adjunct During Femoral Lengthening? A Randomized Trial.
    Park H, Shin S, Shin HS, Kim HW, Kim DW, Lee DH.
    Clin Orthop Relat Res; 2016 Dec 21; 474(12):2705-2711. PubMed ID: 27506971
    [Abstract] [Full Text] [Related]

  • 17. Effect of ultrasound-guided injection of botulinum toxin type A into shoulder joint cavity on shoulder pain in poststroke patients: study protocol for a randomized controlled trial.
    Zheng P, Shi Y, Qu H, Han ML, Wang ZQ, Zeng Q, Zheng M, Fan T.
    Trials; 2024 Jun 27; 25(1):418. PubMed ID: 38937804
    [Abstract] [Full Text] [Related]

  • 18. Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial.
    Zakrzewska JM, Palmer J, Morisset V, Giblin GM, Obermann M, Ettlin DA, Cruccu G, Bendtsen L, Estacion M, Derjean D, Waxman SG, Layton G, Gunn K, Tate S, study investigators.
    Lancet Neurol; 2017 Apr 27; 16(4):291-300. PubMed ID: 28216232
    [Abstract] [Full Text] [Related]

  • 19. The efficacy of botulinum toxin for the treatment of trigeminal and postherpetic neuralgia: a systematic review with meta-analyses.
    Shackleton T, Ram S, Black M, Ryder J, Clark GT, Enciso R.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Jul 27; 122(1):61-71. PubMed ID: 27260275
    [Abstract] [Full Text] [Related]

  • 20. Botulinum neurotoxin type A for the treatment of pain: not just in migraine and trigeminal neuralgia.
    Sandrini G, De Icco R, Tassorelli C, Smania N, Tamburin S.
    J Headache Pain; 2017 Dec 27; 18(1):38. PubMed ID: 28324318
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.